Ensign (ENSG) Receivables - Other (2023 - 2024)
Ensign (ENSG) reported Receivables - Other of $3.8 million for Q3 2024, up 1083.38% year-over-year from $325000.0 in Q4 2023, and up 495.36% quarter-over-quarter from $646000.0 in Q2 2024.
Ensign (ENSG) Receivables - Other (2023 - 2024) Analysis & Trends
Ensign (ENSG) has 2 years of Receivables - Other data on file, last reported at $3.8 million in Q3 2024.
- Receivables - Other for Q3 2024 came in at $3.8 million, up 1083.38% year-over-year; the trailing twelve-month figure through Sep 2024 was $3.8 million (up 1083.38% YoY), and the FY2023 annual result was $1.2 million, changed N/A from the prior year.
- Receivables - Other rose to $3.8 million in Q3 2024 per ENSG's latest filing, from $646000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $3.8 million in Q3 2024 and troughed at $325000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | Concentra Group Holdings Parent | 3.59 Bn | 3.54 Bn | 170.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.85 Mn |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 646,000.00 |
| Mar 31, 2024 | 486,000.00 |
| Mar 31, 2024 | 486,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 325,000.00 |
| Sep 30, 2023 | 325,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.20 Mn |